Your browser doesn't support javascript.
loading
Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
Buocikova, Verona; Longhin, Eleonora Marta; Pilalis, Eleftherios; Mastrokalou, Chara; Miklikova, Svetlana; Cihova, Marina; Poturnayova, Alexandra; Mackova, Katarina; Babelova, Andrea; Trnkova, Lenka; El Yamani, Naouale; Zheng, Congying; Rios-Mondragon, Ivan; Labudova, Martina; Csaderova, Lucia; Kuracinova, Kristina Mikus; Makovicky, Peter; Kucerova, Lucia; Matuskova, Miroslava; Cimpan, Mihaela Roxana; Dusinska, Maria; Babal, Pavel; Chatziioannou, Aristotelis; Gabelova, Alena; Rundén-Pran, Elise; Smolkova, Bozena.
Afiliação
  • Buocikova V; Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Longhin EM; Health Effects Laboratory, NILU-Norwegian Institute for Air Research, 2007 Kjeller, Norway.
  • Pilalis E; e-NIOS Applications P.C., AlexandrouPantou 25, Kallithea 17671, Athens, Greece; Center of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Greece.
  • Mastrokalou C; Center of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Greece.
  • Miklikova S; Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Cihova M; Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Poturnayova A; Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Mackova K; Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Babelova A; Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Trnkova L; Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • El Yamani N; Health Effects Laboratory, NILU-Norwegian Institute for Air Research, 2007 Kjeller, Norway.
  • Zheng C; Norgenotech AS, Ullernchassern, 64/66 Oslo, Norway.
  • Rios-Mondragon I; Department of Clinical Dentistry, University of Bergen, Aarstadveien 19, 5009 Bergen, Norway.
  • Labudova M; Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Csaderova L; Institute of Virology, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Kuracinova KM; Department of Pathology, Faculty of Medicine, Comenius University in Bratislava, Sasinkova 4, 811 08 Bratislava, Slovakia.
  • Makovicky P; Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Kucerova L; Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Matuskova M; Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Cimpan MR; Department of Clinical Dentistry, University of Bergen, Aarstadveien 19, 5009 Bergen, Norway.
  • Dusinska M; Health Effects Laboratory, NILU-Norwegian Institute for Air Research, 2007 Kjeller, Norway.
  • Babal P; Department of Pathology, Faculty of Medicine, Comenius University in Bratislava, Sasinkova 4, 811 08 Bratislava, Slovakia.
  • Chatziioannou A; e-NIOS Applications P.C., AlexandrouPantou 25, Kallithea 17671, Athens, Greece; Center of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Greece.
  • Gabelova A; Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Rundén-Pran E; Health Effects Laboratory, NILU-Norwegian Institute for Air Research, 2007 Kjeller, Norway.
  • Smolkova B; Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia. Electronic address: bozena.smolkova@savba.sk.
Biomed Pharmacother ; 147: 112662, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35091237

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Doxorrubicina / Resistencia a Medicamentos Antineoplásicos / DNA (Citosina-5-)-Metiltransferase 1 / Decitabina Tipo de estudo: Clinical_trials Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Doxorrubicina / Resistencia a Medicamentos Antineoplásicos / DNA (Citosina-5-)-Metiltransferase 1 / Decitabina Tipo de estudo: Clinical_trials Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article